Avantor® Opens New Biobank Facility in Germany to Support Scientific Research and Clinical Trials
Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, just opened its new biorepository and sample archiving facility in Europe. Strategically located near the...
Be The Match BioBank Cryopreservation Service Launched by NMDP/Be The Match
The National Marrow Donor Program® (NMDP)/Be The Match® today announced the launch of a new cryopreservation service, Be The Match BioBank, aimed at providing hematopoietic cell transplant patients, allogeneic blood stem cell donors and physicians a predictable path to transplant. Through...
First Biobank for Chromosome 15 Disorders in Australia
The first biobank in Australia aiming to improve research and treatments into rare genetic diseases caused by changes to genes on chromosome 15, including Prader-Willi Syndrome and Angelman Syndrome, will be established at the Murdoch Children's Research Institute (MCRI). Prader-Willi...
Innate Immunity in ALS: A Biobank to Provide Answers
ALS – Pathology, Morbidity, Mortality Stats
Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease, is adebilitating condition that affects voluntary muscle movements such as walking, talking and breathing. The disease destroys nerve cells in the brain and the...
Medicines Discovery Catapult Creates One of the World’s Largest Virtual Biobanks
Medicines Discovery Catapult (MDC) just announced the rapid expansion of its Biosamples supply network, creating one of the largest virtual biobanks worldwide accessible to life science innovators. MDC welcome Audubon Biosciences, Biomex, Caltag Medsystems and Tissue for Research to its network of patient sample suppliers, building...
Water On The Brain: A Biobank Of Failed Shunt Devices
Hydrocephalus, otherwise known as water on the brain, is a condition where cerebrospinal fluid (CSF) accumulates within the brain. Hydrocephalus that occurs in childhood has a frequency of about 1 person in 1100 within the USA. The surgical placement...
Biobank@VITO – Facilitating Biomonitoring In Belgium
Following a Belgium government decree in 2003, the Flemish
Centre of Expertise on Environment and Health was founded by the Department of
Economics, Science and Innovation; Flemish Agency for Care and Health; and Department
of Environment, Nature and Energy. The mandate was...
A Living Biobank Of Ovarian Cancer – A Model For Drug Discovery
Synthetic lethality is a circumstance in which a drug is selectively
deadly to cancer cells due to the mutations and genetic changes that have
occurred during oncogenesis and progression. Oftentimes a cancer will lose redundancy,
that is it will jettison certain survival/...
A Living Biobank Of Non-Small Cell Lung Cancer Organoids
Globally, cancer of the lung is the most common cause of
cancer related mortality. It is also the most commonly diagnosed. 3D patient derived
organoids provide a more faithful model of cancer than 2D in vitro cell
culture and represent a model...
The Swedish p53 Study (SWEP53) With Biobank Option
The Swedish p53 Study (SWEP53) is a germ line TP53 pathogenic variant patient registry with three optional parts: a biobank, a surveillance program and a psychosocial evaluation of the surveillance. The full study outline was published in the journal...
